Ashwin Yardi says Covid-19 validated and boosted the offshoring model, and India's IT services industry is expanding faster into tier II and tier III locations
15 January 2021
Share
India s Bhabha Atomic Research Centre (BARC) has developed a process to harvest medical-grade ruthenium-106, allowing the indigenous production of plaques of the material for use in eye cancer therapy. Ruthenium is a fission by-product of the nuclear reprocessing cycle.
BARC s round (a) and notched (b) Ru-106 plaques (Image: DAE)
The use of ruthenium plaques - curved metal discs containing the radioactive isotope - is a proven technique for the treatment of different types of eye cancers, but its availability in India has been limited owing to expensive imported sources, India s Department of Atomic Energy (DAE) has said. The availability of indigenously produced Ru-106 plaques will reduce the cost of treatment and help to save the vision of a large number of patients, it added.